| Mallory Meyer, | |
|
1790 N State St, Orem, UT 84057-2025 | |
| (801) 224-8255 | |
| (801) 224-8301 |
| Full Name | Mallory Meyer |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 1790 N State St, Orem, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033520069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mallory Meyer, 1790 N State St, Orem, UT 84057-2025 Ph: (801) 224-8255 | Mallory Meyer, 1790 N State St, Orem, UT 84057-2025 Ph: (801) 224-8255 |
News Archive
AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) announced overall survival (OS) for tivozanib, an investigational agent, from the Phase 3 TIVO-1 (TIvozanib Versus sOrafenib in 1st line advanced RCC) study in patients with advanced renal cell carcinoma (RCC). The final OS analysis, as specified by the protocol, shows a median OS of 28.8 months (95% confidence interval [CI]: 22.5–NA) for tivozanib versus a median OS of 29.3 months (95% CI: 29.3–NA) for the comparator arm, sorafenib.
Levels of a gene that helps the immune system differentiate the good cells from the bad could be a good indicator of prognosis in people with colorectal cancers, Medical College of Georgia researchers report.
Tenet Healthcare Corporation today announced that its Board of Directors, after consulting with its independent financial and legal advisors, has unanimously determined that the revised proposal from Community Health Systems, Inc. to acquire all of the outstanding shares of Tenet for $6.00 per share in cash grossly undervalues the Company and is not in the best interests of Tenet or its shareholders.
A new study led by researchers at Boston Medical Center indicates that variations in opioid receptor genes are associated with more severe neonatal abstinence syndrome (NAS) in newborn babies. The findings, published online in Drug & Alcohol Dependence, could help lead to the development of individualized treatment plans tailored to each infants' risk of requiring medication to curb their NAS symptoms, which could help improve these patients' outcomes and reduce how long some stay in the hospital.
Carbon monoxide is known by many as a poisonous gas that causes brain injury and other neurological symptoms, including memory loss and confusion. But a new study led by investigators at Beth Israel Deaconess Medical Center suggests the opposite may be true: When administered in small, carefully controlled amounts, carbon monoxide may actually protect the brain from damage following subarachnoid hemorrhage, a devastating stroke that results from bleeding in the brain.
› Verified 8 days ago
Skyler Anderson, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 276 E 950 S, Orem, UT 84058 Phone: 801-845-4406 | |
Levi Josefsson, MT-BC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2066 W 885 S, Orem, UT 84059 Phone: 310-748-9271 | |
Taylor Madsen, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 489 W 1400 N, Orem, UT 84057 Phone: 801-885-7970 | |
Christopher Wallace, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1790 N State St, Orem, UT 84057 Phone: 801-224-8255 Fax: 801-224-8301 | |
Stephen Gordon Anderson, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 525 N 1080 E, Orem, UT 84097 Phone: 801-368-1313 | |
Rochelle Maki, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 395 E 1600 S, Orem, UT 84058 Phone: 937-286-1500 |